Premium
Bicara Therapeutics Inc (BCAX)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| T. Rowe Price Group, Inc. | Institution | 7 981 978 | 12,15% | US$ 162,91M | 2026-03-31 |
| RA Capital Management, L.P. | Institution | 7 255 993 | 11,04% | US$ 148,09M | 2026-03-31 |
| Biocon Limited | Institution | 5 523 897 | 8,41% | US$ 112,74M | 2026-04-15 |
| Vestal Point Capital, LP | Institution | 5 425 000 | 8,26% | US$ 110,72M | 2026-03-31 |
| Invus Public Equities, L.P. | Institution | 5 216 969 | 7,94% | US$ 106,48M | 2026-04-15 |
| Artal Group S.A. | Institution | 5 216 969 | 7,94% | US$ 106,48M | 2026-04-15 |
| RA Capital Healthcare Fund, L.P. | Institution | 4 603 418 | 7,01% | US$ 93,96M | 2026-02-26 |
| Deep Track Biotechnology Master Fund, Ltd | Institution | 4 062 500 | 6,18% | US$ 82,92M | 2026-03-31 |
| Deep Track Capital, LP | Institution | 4 062 500 | 6,18% | US$ 82,92M | 2026-03-31 |
| Janus Henderson Group plc | Institution | 3 339 218 | 5,08% | US$ 68,15M | 2026-03-31 |
| Red Tree Venture Fund, L.P. | Institution | 3 170 509 | 4,83% | US$ 64,71M | 2026-03-31 |
| Red Tree Venture Capital | Institution | 3 170 509 | 4,83% | US$ 64,71M | 2026-03-31 |
| TPG Capital, L.P. | Institution | 3 010 425 | 4,58% | US$ 61,44M | 2026-03-31 |
| BlackRock, Inc. | Institution | 2 843 535 | 4,33% | US$ 58,04M | 2026-03-31 |
| RA Capital Nexus Fund III, L.P. | Institution | 2 652 575 | 4,04% | US$ 54,14M | 2026-02-26 |
| Omega Fund Management, LLC | Institution | 2 392 150 | 3,64% | US$ 48,82M | 2026-03-31 |
| RP Management, LLC | Institution | 2 388 150 | 3,63% | US$ 48,74M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 1 774 220 | 2,70% | US$ 36,21M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 1 659 342 | 2,53% | US$ 33,87M | 2026-03-31 |
| Franklin Resources, Inc. | Institution | 1 605 613 | 2,44% | US$ 32,77M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 1 419 388 | 2,16% | US$ 28,97M | 2026-03-31 |
| Jones Hill Capital LP | Institution | 1 260 136 | 1,92% | US$ 25,72M | 2026-03-31 |
| F-Prime Capital Partners Life Sciences Fund Vii Lp | Institution | 1 115 333 | 1,70% | US$ 22,76M | 2024-09-16 |
| FMR LLC | Institution | 1 078 489 | 1,64% | US$ 22,01M | 2026-03-31 |
| Impresa Management LLC | Institution | 1 022 389 | 1,56% | US$ 20,87M | 2026-03-31 |
| Eight Roads Ventures India Healthcare IV, L.P. | Institution | 1 013 853 | 1,54% | US$ 20,69M | 2024-09-16 |
| Deerfield Partners, LP | Institution | 897 587 | 1,37% | US$ 18,32M | 2024-09-17 |
| Deerfield Private Design Fund V, L.P. | Institution | 897 587 | 1,37% | US$ 18,32M | 2024-09-17 |
| Geode Capital Management, LLC | Institution | 830 906 | 1,26% | US$ 16,96M | 2026-03-31 |
| Fidelity International Ltd | Institution | 679 904 | 1,03% | US$ 13,88M | 2026-03-31 |
| OrbiMed Advisors LLC | Institution | 667 300 | 1,02% | US$ 13,62M | 2026-03-31 |
| Acorn Bioventures | Institution | 643 382 | 0,98% | US$ 13,13M | 2026-03-31 |
| Aisling Capital Management LP | Institution | 568 919 | 0,87% | US$ 11,61M | 2026-03-31 |
| Palo Alto Investors LP | Institution | 550 408 | 0,84% | US$ 11,23M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 524 356 | 0,80% | US$ 10,70M | 2026-03-31 |
| Rock Springs Capital Management LP | Institution | 489 095 | 0,74% | US$ 9,98M | 2026-03-31 |
| Dr. Kiran Mazumdar-Shaw | Initiés | 449 405 | 0,68% | US$ 9,17M | 2026-04-15 |
| Nan Fung Trinity (HK) Limited | Institution | 427 885 | 0,65% | US$ 8,73M | 2026-03-31 |
| Dafna Capital Management, LLC | Institution | 421 733 | 0,64% | US$ 8,61M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
